Staining Patterns in Dry Eye Syndrome: Rose Bengal Versus Trypan Blue Rosane S. Castro (1) Lívia M. D. Freire (1), Renato Ambrosio Jr(2) 1-Ophthalmology.

Slides:



Advertisements
Similar presentations
1 Sjögren‘s Syndrome 1.Ocular symptoms 2.Oral symptoms 3.Ocular signs 4.Histopathology 5.Salivary gland involvement 6.Autoantibodies In patients without.
Advertisements

World Cornea Congress VII Loteprednol Etabonate 0.5% Versus Cyclosporine 0.05% for Dry-Eye Syndrome After Bone Marrow Transplantation: A Prospective Randomized.
Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.
Physician Compliance With the HEDS Recommendation of Antiviral Prophylaxis in Patients Diagnosed With Herpetic Stromal Keratitis at KEI Sameen Zaidi M.D.
Vatinee Y. Bunya, MD, Mina Massaro-Giordano, MD, Frederick B. Vivino, MD*, Stephen E. Orlin, MD, Michael E. Sulewski, MD, and Maureen G. Maguire, PhD The.
EVIDENCE BASED MEDICINE for Beginners
Incidence of Blepharitis in Patients Undergoing Phacoemulsification Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have.
Biostatistics and Research Design, #6350 Sampling
Delay in Symptom Resolution After Thermal Pulsation System Treatment for Meibomian Gland Dysfunction in Dry-Eye Disease Delay in Symptom Resolution After.
Non-Invasive Keratograph Tear Break-Up Time versus Invasive Fluorescein-Associated Tear Stability Test: Experimental Validation Study Nizar S Abdelfattah,
Epitheliopathy in the Region of the Eyelid Associated with the Caruncle in Normal Subjects and Dry-Eye Patients Epitheliopathy in the Region of the Eyelid.
Journal Club Alcohol and Health: Current Evidence July–August 2005.
Yousef A Alghamdi, MD; Allison L McClellan, OD; Nabeel M Shalabi, MD Anat Galor, MD, MSPH Supported by the Department of Veterans Affairs, Veterans Health.
INTRODUCTION TO ICD-9-CM PART TWO ICD-9-CM Official Guidelines (Sections II and III): Selection of Principal Diagnosis/Additional Diagnoses for Inpatient.
Siamak Zarei-Ghanavati M.D., FICO
1. Vision Changes  You may notice vision changes with aging.  Many changes are common and can often be corrected.  As you get older, you are at higher.
Young Joo Shin 1, Joo Hyun Kim 1, Jung Ha Kim 2, Woo Ho Nam 1, Kayoung Yi 1, Joon Young Hyon 3, 1 Department of Ophthalmology, Hallym University College.
W. B. Trattler; C. D. Reilly; D. F. Goldberg; P. A. Majmudar; J. A. Vukich; M. Packer; E. D. Donnenfeld.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Copyright restrictions may apply Sensitivity and Specificity of a Point-of-Care Matrix Metalloproteinase 9 Immunoassay for Diagnosing Inflammation Related.
Elvin H. Yildiz, Elisabeth J. Cohen, Ajoy S. Virdi, Kristin M. Hammersmith, Peter R Laibson, and Christopher J. Rapuano Cornea Service, Wills Eye Institute,
The Nature of Disease.
Association between Depression And Dry eye Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Young Joo Shin, MD, 1 Won Ryang Wee, MD, 2 Jin Hak Lee, MD, 1 1.
Chapter 20 Patient Interview. 2 3 Learning Objectives  Define and spell key terms  Define the purpose and the key components of the patient interview.
Blepharitis and Dry eyes in Aromatase Inhibitor Users
Bepotastine Besilate Ophthalmic Solution 1.5% and Degree of Reduced Ocular Itching in a Conjunctival Allergen Challenge Test JI Williams 1, G Torkildsen.
Effects of Xalatan® (latanoprost) or Travatan® (travoprost) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients. M.B. McDonald1,
Bruce H. Koffler, MD University of Kentucky School of Medicine The author of this poster has received research funding and travel expense reimbursement.
Ocular Comfort Assessment of Bepotastine Besilate Ophthalmic Solution 1.5% in Multicenter Conjunctival Allergen Challenge Clinical Trial JA Gow 1, TT Macejko.
Results Recruitment 507 out of 4417 patients were eligible to take part in the study 131 of them (25.5%) participated in the study Demographics Male-female.
Autologous serum eye drops in severe post-LASIK dry eye.
Integrated Trial Results of Bepotastine Besilate Ophthalmic Solution 1.5% on Eyelid Swelling in a Clinical Model of Allergic Conjunctivitis TR McNamara.
Evaluation of Epithelial Changes in Limbal Stem Cell Deficiency Using in Vivo Confocal Microscopy ERIC CHAN, Luxia Chen, Sophie X. Deng Cornea and Uveitis.
Comparison of Bromfenac vs. Ketorolac During the Induction Phase of Treatment with Topical Cyclosporine for Dry Eye Patients Barry A. Schechter, MD Florida.
Vision related quality of life in persons with Dry eye syndrome using the 25 item National eye Institute visual function questionnaire S.P. Mahesh MD Janine.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Tear-film Stability in Patients with Obstructive Sleep Apnea Syndrome Masaki Sato, MD Tetsuro Oshika, MD Department of Ophthalmology University of Tsukuba.
Evaluation of Systane® versus Placebo in Corneal Epithelial Healing Following Photorefractive Keratectomy (PRK) Lt Col Charles D. Reilly Major Vasudha.
The authors have no financial interest
Oliver Findl 1,2, Nino Hirnschall 1,2, Alja Crnej 2 1 VIROS Vienna Institute for Research in Ocular Surgery, Hanusch Hospital, Vienna, Austria 2 Moorfields.
World Cornea Congres Ready-made allogenic serum eye drops for severe dry eye disease. Hanne Olsen Julian, MD, Ph.D. Henrik Bom Olesen, MD. Morten.
FLUORESCEIN CLEARANCE TEST AS AN ADDITIONAL DIAGNOSTIC TOOL FOR DYSFUNCTIONAL TEAR SYNDROME Rodrigo de Nápole Azevêdo, MD Jamília Barros da Silva, MD Aline.
Quantification of Soluble Cytokines in Sjögren Disease, non Sjögren dry eye and Healthy Subjects M. Jaimes 1B, C. Santacruz-Valdes 1B, Y. Garfias 1A, T.
David R. Hardten 1, Mark Milner 2, Jai G. Parekh 3, Neda Shamie 4, Darrell E. White 5 and Michael Schiewe 6 Financial Disclosures: Dr’s Hardten, Milner,
Peter A SimmonsA Cindy Carlisle-WilcoxA Perry S BinderB
Prevalence of Dry Eye Disease among Elderly Korean Population Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Won Ryang Wee, MD, 2,3 Jin Hak Lee, MD, 1, 3.
Correlation of Conjunctival and Corneal Staining With Elevated Matrix Metalloproteinase-9 on the Ocular Surface of Dry-Eye Patients Authors: Allister Gibbons,
DEVELOPING AND VALIDATION OF AN ARABIC VERSION OF THE VISUAL FUNCTIONING INDEX VF14 FOR CATARACT PATIENTS Abdulrahman Al-Muammar, MD, FRCSC King Abdul.
STAINING R.SEENIAMMAL AEH, THENI.
Topical Cyclosporine 0.05% as a Long-Term Monotherapy for Atopic Keratoconjunctivitis Jonathan H. Tzu, M.D ¹, * ; C. Asli Utine, M.D ¹,², * Michael Stern,
Comparison of Efficacy of 0.05% Cyclosporine Ophthalmic Emulsion
1 Conjunctival Goblet cell Density Following Sequential Therapy With Artificial Tear and Cyclosporine 0.05% Frank A. Bucci, Jr, MD 1 ; Stephen C. Pflugfelder,
Efficacy of Topical Azithromycin & Cyclosporine A(CsA) vs CsA Alone in the Treatment of Dry Eyes Associated with Blepharitis Kenneth A. Beckman, M.D.,
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Awareness and Knowledge of Emergent Ophthalmic Disease Uhr JH, Mishra K, Wei C,
Comparing Factors Affecting Surgically Induced Astigmatism
A Case of Beauveria Bassiana Keratitis Confirmed by Gene Sequencing Sung-Dong Chang, M.D., Jong-Hwa Jun, M.D. Department of Ophthalmology, School of Medicine,
A2 unit 4 Clinical Psychology 4) Content Reliability of the diagnosis of mental disorders Validity of the diagnosis of mental disorders Cultural issues.
1. Ankara University School of Medicine, Department of Ophthalmology
Limited Scleroderma (CREST Syndrome) is associated with worse
From: Lower Vitamin D Level and Distinct Tear Cytokine Profile Were Observed in Patients with Mild Dry Eye Signs but Exaggerated Symptoms Trans. Vis. Sci.
EVALUATION OF OCULAR SURFACE DISEASE IN PATIENTS AFTER TRABECULECTOMY: COMPARATIVE STUDY WITH AND WITHOUT INTRACAMERAL BEVACIZUMAB Sónia Parreira; Sandra.
Finger prick Autologous Blood (FAB) as a novel approach to treatment of non-healing corneal epithelial defects and dry eyes James R Wawrzynski, Jonathan.
A Randomised Cross Over Comparison of Trehalose/Hyaluronate Eye Drops and Standard Treatment: Patient Satisfaction in the Treatment of Dry Eye Syndrome.
Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD
A presentation to: Meeting name Date
Conjunctival Impression Cytology in healthy volunteers
Sirel G. Güngör, MD Cem Küçükerdönmez, MD Yonca A. Akova, MD
Yumiko Ban,1,2,3) Seika Den,2) Jun Shimazaki,2,3)
I-Chan Lin MD, Paul P. Lee MD, JD
Presentation transcript:

Staining Patterns in Dry Eye Syndrome: Rose Bengal Versus Trypan Blue Rosane S. Castro (1) Lívia M. D. Freire (1), Renato Ambrosio Jr(2) 1-Ophthalmology Department UNICAMP-SP 2-Renato Ambrosio Eye Institute, Rio de Janeiro-RJ

Introduction ► Dry eye syndrome (DES) is a somewhat common disorder found in ophthalmic daily practice, it can be associated with many local and/or systemic disorders, and sometimes is a diagnostic challenge because of the lack of association between symptoms and clinical findings. ► There is no described gold standard diagnostic test that could reliably diagnose and stage the disease in every case. ► A number of different testings are commonly performed to help determining an accurate diagnosis of DES. These include subjective (as questionnaires) and objective ones, like tear breakup time (tBUT), ocular surface dye staining [fluorescein, rose bengal (RB), or lissamine green (LG)], Schirmer test, and conjunctival impression cytology.

Introduction ► Since its first report in ophthalmic practice, RB is one of the most used stains, examiner friendly, but providing a great patient discomfort. It is able to bind to epithelial cells that are uncoated by certain proteins (mainly mucin) and presents high cell toxicity. ► The Trypan Blue is reported to be used in ophthalmology since Although it is known to stain dead cells as well as cells that had been injuried, this vital dyer is not used much in the clinical practice for staining of the ocular surface. The Trypan Blue is considered to be toxic in certain manner for epithelial cells, however it is more torelable than the Rose Bengal on the patient´s eyes

Purpose ► In the present study, we evaluated and compared staining properties and patient’s tolerance for both RB and TB in DES and assessed the correlation of disease severity with staining patterns.

MATERIALS AND METHODS ► This was a prospective, randomized, comparative, crossover-fashioned study. The study protocol was approved by the State University of Campinas (UNICAMP) Review Board and followed the Declaration of Helsinki. ► Patients were randomly selected from the external eye disease ambulatory, Department of Ophthalmology of UNICAMP. ► Patients with any other ocular surface disorders, previous ocular surgery, contact lens wearers, and those who were using eyedrops other than lubricants were excluded. ► A validated questionnaire, the Ocular Surface Disease Index (OSDI, ranging from 0 to 100 points), reviewed elsewhere, was used to classify disease severity. ► Two percent fluorescein drops were used to measure tBUT. Then, both 1% RB and 1% TB drops were applied. Patients were randomly divided in 2 groups, regarding dye instillation order (group 1: RB first; group 2: TB first). The second dye was applied 1 hour apart (or after the first drop was washed out, whichever occurred last). An anesthetic drop preceded both.

MATERIALS AND METHODS ► A staining score (van Bijsterveld scale, ranging from 0 to 9) was used to evaluate the results, which were obtained by the same examiner. Staining scores for both RB and TB were compared between each other in both groups. The scores were also correlated to disease severity (measured by the OSDI score). ► Patient comfort to the colorant drop was evaluated by an objective questionnaire. After receiving the first drop, the patient was asked the question: ‘‘Did this drop feel uncomfortable?’’ and the patient answered either ‘‘yes’’ or ‘‘no.’’ When the second drop was applied, the question was asked again ► Clinical data were compared using a paired t test (for age, OSDI score, and tBUT), Fisher exact test (for patient sex, etiology, and comfort questionnaire), and Pearson r correlation test (for RB vs TB staining scores and for disease severity vs staining scores).

Van Bijsterveld Right Eye(RE) Left Eye(LE) Right Eye(RE) Left Eye(LE) ► 1 –temporal conjuctiva ► 2 - cornea ► 3 –nasal conjuctiva ► Punctuation ► 0 point ► 1 point ► 2 points ► 3 points ► Total= (1+2+3)RE+(1+2+3)LE 2

Results Group 1 Group 2 p Sex Female Male33 Etiology evaporative32 non SS Primary SS Secondary SS Age 52 ± ± OSDI 24 ± ± BUT 4 ± ± Table 1 - Patient Demographics and Clinical Features SS= Sjögren Syndrome OSDI= ocular surface desease index BUT= Breakup timeGroupEyesDye ± mean ± SD p Group 1 14TB 5.3 ± RB 6.2 ± 1.9 Group 2 14TB 6.2 ± 2.0 <0.001 RB 5.9 ± 1.9 Table 2 – Staining Scores TB – Trypan blue BR – Bengal rose

DISCUSSION ► Vital staining of the ocular surface remains a very useful, easy, and inexpensive diagnostic test in patients with dry eye. ► Among available stains, fluorescein and RB are still the most commonly used. Recent studies with RB warned for its toxicity, including decreasing the chance to recover herpes viruses in human cell cultures.It is also known to provide a great patient discomfort. ► As an alternative, TB staining has been used as a dye in cataract surgery. It seems to be a less toxic stain, providing less stinging upon instillation. They are easily observed under the slit-lamp examination, seen as blue (TB) or pink (RB) punctate or confluent staining of the ocular surface. ► Our main goal was to compare both stains in both eyes of the same patients in a crossover fashion. This criterion was used to try to eliminate any bias regarding staining properties (would the first drop interfere in the second drop score?). Besides this, patients were examined in only 1 visit, so that any alteration in patients’ ocular surface would not compromise the results in a second visit.

DISCUSSION ► As reported in other studies, we found a poor correlation between patient symptoms (assessed by the OSDI score) and signs (measured by the staining scores). One observation to be made is that currently there are no validated OSDI translations to Portuguese language, although Allergan, Inc, (Irvine, CA) provides it in a translated form in Brazil. Also, all patients included in this study were receiving treatment (with artificial teardrops) for their disease, which could possibly alter the results (both for the questionnaire and staining scores). ► In conclusion, both TB and RB showed similar staining patterns. RB was found to provide greater patient discomfort. There was no correlation between disease severity (addressed by the ocular surface disease index questionnaire) and staining patterns (measured by the van Bijsterveld scale).